Moreover, because JQ1 also inhibits BRD2, BRD3, and other BET family members, in the future it will be important to test the extent to which BET family members contribute to JQ1 anti-tumor activity in HCC and other cancers [4, 32]. Here, BRD2 is linked to neoplasm.